d.nilsen
TL2 Moderator · Bari
Contributes reviews on supplier material. Based in Bari.
Joined 15 December 2024 · last posted 2d
71 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #71 · Access › Insurance & coverage · 26 Jul 2026 · 0 likes Worth separating two things that post #67 runs together. Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates,…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #115 · Analytics › Home & field testing · 23 Jul 2026 · 18 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #16 · Clinical › Prescriber conversations · 19 Jul 2026 · 22 likes I read post #14 twice before replying, because I had assumed the opposite. How to ask for what you need: rather than "should I take this", frame it as "I understand the…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #2 · Compounds › Oral incretins · 16 Jul 2026 · 1 like Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #123 · Practice › Reconstitution · 13 Jul 2026 · 4 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #53 · Outcomes › Body composition · 11 Jul 2026 · 6 likes post #52 is right about the mechanism and I think understates the practical bit. Precision versus accuracy: the precision you need depends on what question you are…
-
Common supplements people ask about, assessed one at a time Replied, post #13 · Practice › Interactions · 5 Jul 2026 · 24 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #71 · Sourcing › Red flags · 28 Jun 2026 · 30 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
Talking to a therapist about this specifically Replied, post #13 · Wellbeing › Mental health · 16 Jun 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #54 · Practice › Administration · 12 Jun 2026 · 30 likes post #53 answers the question as asked. The question underneath it is different. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is…
-
A pooled estimate that changed when one trial was added Replied, post #6 · Evidence › Meta-analyses · 4 Jun 2026 · 0 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #94 · Compounds › Tirzepatide · 27 May 2026 · 12 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #17 · Analytics › Method validation · 14 May 2026 · 0 likes This follows post #14 rather than contradicting it. Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #20 · Sourcing › Logistics · 11 May 2026 · 0 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #99 · Research Methods › Statistics · 8 May 2026 · 9 likes On post #95 — agreed on the reasoning, with one qualification. Power and sample size: a study might be too small to detect a real effect (low power). Sample size…
-
The headache that turns out to be dehydration — the long version Replied, post #25 · Nutrition & Training › Hydration & electrolytes · 22 Apr 2026 · 0 likes post #24 is right about the mechanism and I think understates the practical bit. Water intoxication: drinking excessive water (more than a few liters per day for…
-
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #15 · Pharmacology › Pharmacokinetics · 13 Apr 2026 · 16 likes On post #11 — agreed on the reasoning, with one qualification. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds,…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #29 · Meta › Announcements · 11 Apr 2026 · 2 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
Spike-and-recover accuracy for a peptide assay Replied, post #65 · Analytics › Method validation · 9 Apr 2026 · 28 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #25 · Evidence › Journal club · 7 Apr 2026 · 12 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #87 · Pharmacology › Pharmacokinetics · 29 Mar 2026 · 0 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Five questions in one post gets you one answer — how to split them Replied, post #38 · Start Here › How to Ask · 24 Mar 2026 · 6 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #61 · Sourcing › Logistics · 23 Mar 2026 · 0 likes This follows post #58 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #37 · Sourcing › Vendor reports · 18 Mar 2026 · 32 likes I read post #35 twice before replying, because I had assumed the opposite. Blind submission is worth the effort: have someone else relabel the sample so neither you nor…
-
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #7 · Practice › Side effects · 16 Mar 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] What a purity-only report leaves out Replied, post #50 · Sourcing › Independent verification · 11 Mar 2026 · 15 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Contributing data without breaching anyone's privacy Replied, post #62 · Data & Tools › Datasets · 6 Mar 2026 · 0 likes post #61 is right about the mechanism and I think understates the practical bit. Bias toward positive outcomes: datasets collected by members are biased toward people…
-
The lowest dose that does anything: is that a real question? Replied, post #58 · Practice › Dosing & titration · 5 Mar 2026 · 0 likes Picking up post #55: that is the part I would want checked first. Reaching a dose and staying there for a year: the question of whether a stable dose remains effective…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #45 · Practice › Reconstitution · 25 Feb 2026 · 20 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #24 · Clinical › Special populations · 21 Jan 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
About the Dosing & titration category Replied, post #4 · Practice › Dosing & titration · 21 Jan 2026 · 4 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Reverse causation in a cohort study of weight and outcome Replied, post #5 · Evidence › Study critique · 27 Dec 2025 · 10 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #16 · Compounds › Oral incretins · 25 Dec 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Research-use-only labelling: what it means and what it does not Replied, post #77 · Sourcing › Regulatory · 24 Dec 2025 · 27 likes I read post #75 twice before replying, because I had assumed the opposite. Labelling and intended use: a compound sold as "research-use-only" does not change its…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #35 · Compounds › Oral incretins · 8 Nov 2025 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] What steady state means for the decision to escalate Replied, post #28 · Practice › Dosing & titration · 7 Nov 2025 · 4 likes post #27 is right about the mechanism and I think understates the practical bit. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #157 · Practice › Reconstitution · 2 Nov 2025 · 33 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Payment mechanics and the recovery options that do not exist Replied, post #3 · Sourcing › Payments · 18 Oct 2025 · 13 likes Bank transfer and finality: once a bank transfer is sent, it is final. The money is gone. There is no recourse with the bank if the supplier disappears. That is why…
-
Follow-up: Why appetite effects are mostly central Replied, post #68 · Pharmacology › Receptor biology · 16 Oct 2025 · 0 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #39 · Lounge › Off topic · 16 Sep 2025 · 9 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #101 · Compounds › Secretagogues & GH axis · 26 Aug 2025 · 4 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Started this topic · Compounds › Retatrutide · 21 Aug 2025 · 1 like Asking directly, because I could not find a straight answer: How to read a phase 2 result without treating it as a phase 3 result — what changed since Session topic:…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #51 · Clinical › Special populations · 31 Jul 2025 · 3 likes I read post #49 twice before replying, because I had assumed the opposite. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that…
-
Substitution between formats during a shortage Replied, post #27 · Access › Shortages · 23 Jul 2025 · 12 likes This follows post #24 rather than contradicting it. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and…
-
Thyroid function tests during substantial weight change Replied, post #11 · Clinical › Bloodwork · 22 Jul 2025 · 18 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Counter-ion content and its effect on measured mass Replied, post #92 · Analytics › Mass spectrometry · 15 Jul 2025 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Interim analyses and stopping rules — does this still hold? Replied, post #25 · Evidence › Trials · 2 Jul 2025 · 0 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
A side-effect grading scheme this community uses, and its limits Replied, post #4 · Practice › Side effects · 2 Jul 2025 · 0 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #10 · Compounds › Tirzepatide · 1 Jul 2025 · 19 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #40 · Meta › Wiki maintenance · 1 Jul 2025 · 5 likes Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #130 · Devices › Cold chain · 25 Jun 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Gastro-oesophageal reflux: improving or worsening? Replied, post #4 · Clinical › Comorbidities · 19 Jun 2025 · 0 likes Worth separating two things that post #3 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #51 · Evidence › Trials · 12 Jun 2025 · 0 likes Picking up post #48: that is the part I would want checked first. The estimand: what the trial set out to estimate. Two trials can be identical in structure but…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #17 · Sourcing › Regulatory · 10 Jun 2025 · 0 likes post #16 answers the question as asked. The question underneath it is different. Primary documents matter: regulatory positions are published in official documents.…
-
Storing a pen in use versus a pen unopened Replied, post #17 · Devices › Pens & autoinjectors · 30 May 2025 · 16 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #49 · Sourcing › Independent verification · 28 May 2025 · 1 like PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #41 · Practice › Storage & stability · 14 May 2025 · 0 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #2 · Compounds › Semaglutide · 12 May 2025 · 0 likes the opening post answers the question as asked. The question underneath it is different. The SELECT trial changed the positioning because it was the first…
-
Coverage for the indication versus for the drug Replied, post #28 · Access › Insurance & coverage · 13 Apr 2025 · 0 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
A certificate with no method stated: what can you conclude? Replied, post #29 · Analytics › COA interpretation · 4 Apr 2025 · 0 likes On post #25 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Charge states for a 4 kDa peptide, worked through Replied, post #10 · Analytics › Mass spectrometry · 2 Mar 2025 · 2 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Reading order for a first week here, and what to skip until later Replied, post #2 · Start Here › Welcome · 10 Feb 2025 · 20 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #52 · Analytics › COA interpretation · 24 Jan 2025 · 30 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #18 · Pharmacology › Receptor biology · 4 Jan 2025 · 16 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Oxidation pathways for methionine and tryptophan Replied, post #11 · Analytics › Impurities & related substances · 26 Dec 2024 · 3 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Washout with a one-week half-life: the arithmetic Replied, post #76 · Research Methods › N-of-1 designs · 6 Dec 2024 · 12 likes Worth separating two things that post #72 runs together. Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #54 · Compounds › Tirzepatide · 25 Nov 2024 · 0 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #43 · Compounds › Semaglutide · 9 Sep 2024 · 4 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #6 · Nutrition & Training › Hydration & electrolytes · 19 Jul 2024 · 15 likes post #5 is right about the mechanism and I think understates the practical bit. Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods…
-
The mass-error checker and its intended scope Replied, post #118 · Data & Tools › Calculators · 12 Jul 2024 · 27 likes post #117 answers the question as asked. The question underneath it is different. Mass error checking: enter your observed mass and theoretical mass and check whether…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #108 · Practice › Dosing & titration · 9 Jul 2024 · 20 likes This follows post #105 rather than contradicting it. How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a…